A novel technology for hormone detection

The ICDx project is developing a novel assay technology that delivers unprecedented sensitivity and robustness for hormone detection.

Currently in the research and developing stage at the University of Turku – funded by Business Finland.

about our technology

The immunocomplex platform

ICDx is a next-generation hormone testing platform based on novel high-affinity immunocomplex antibodies.

ICDx technology enables a faster, more accurate, and cost-effective alternative to conventional diagnostic methods

The ICDx team

Our team of researchers and commercialization experts work together to bring the diagnostic science into real-world applications.

Send us a message!